InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Olema Pharmaceuticals, Inc.

OLMA Clue Score20
United States Fiscal year ends December CIK 0001750284 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

26
Insider
Date
Role
Action
Shares
Price
Amount
Cyrus Harmon
30 Jul 2024
Director
Sold on a plan
934
$15.55
$14.52K
Cyrus Harmon
29 Jul 2024
Director
Sold on a plan
4,066
$15.58
$63.35K
Cyrus Harmon
11 Jul 2024
Director
Sold on a plan
5,000
$12.26
$61.30K
Cyrus Harmon
28 Jun 2024
Director
Sold on a plan
20,000
$10.77
$215.40K
Cyrus Harmon
4 Jun 2024
Director
Sold on a plan
5,000
$12.33
$61.65K
Cyrus Harmon
3 Jun 2024
Director
Sold on a plan
5,000
$10.93
$54.65K
Cyrus Harmon
31 May 2024
Director
Sold on a plan
15,000
$9.41
$141.15K
Cyrus Harmon
6 May 2024
Director
Sold on a plan
5,000
$10.92
$54.60K
Cyrus Harmon
30 Apr 2024
Director
Sold on a plan
15,000
$9.51
$142.65K
Cyrus Harmon
28 Mar 2024
Director
Sold on a plan
20,000
$10.97
$219.40K
Cyrus Harmon
29 Feb 2024
Director
Sold on a plan
100
$13.00
$1.30K
Cyrus Harmon
29 Feb 2024
Director
Sold on a plan
24,900
$12.41
$309.01K
Cyrus Harmon
1 Feb 2024
Director
Sold on a plan
5,000
$15.56
$77.80K
Cyrus Harmon
31 Jan 2024
Director
Sold on a plan
25,000
$12.23
$305.75K
Cyrus Harmon
30 Nov 2023
Director
Sold on a plan
25,000
$12.57
$314.25K
David C. Myles
8 Nov 2023
Ch. Discov. & Non-Clin Dev Off
Sold on a plan
200
$17.61
$3.52K
David C. Myles
3 Nov 2023
Ch. Discov. & Non-Clin Dev Off
Sold on a plan
541
$17.51
$9.47K
Cyrus Harmon
2 Nov 2023
Director
Sold on a plan
5,000
$15.64
$78.20K
David C. Myles
2 Nov 2023
Ch. Discov. & Non-Clin Dev Off
Sold on a plan
3,332
$15.36
$51.18K
David C. Myles
1 Nov 2023
Ch. Discov. & Non-Clin Dev Off
Sold on a plan
6,668
$15.02
$100.15K
Cyrus Harmon
31 Oct 2023
Director
Sold on a plan
25,000
$12.05
$301.25K
Cyrus Harmon
29 Sep 2023
Director
Sold on a plan
25,000
$12.41
$310.25K
David C. Myles
19 Sep 2023
Ch. Discov. & Non-Clin Dev Off
Sold on a plan
20,000
$12.67
$253.40K
Cyrus Harmon
5 Sep 2023
Director
Sold on a plan
10,000
$11.62
$116.20K
Cyrus Harmon
31 Aug 2023
Director
Sold on a plan
15,000
$9.36
$140.40K
Cyrus Harmon
16 Aug 2023
Director
Sold on a plan
15,000
$10.14
$152.10K
Show all 162 transactions →

What was left out

Form 4 filings counted 203
Amendments (4/A) skipped 14
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 36
Sales at will 65
Transactions with no price 2
Shares from compensation/vesting 24,931,528
Sales filed before the plan box existed 11
History held since 19 Nov 2020